Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents
(2014) In European Journal of Medicinal Chemistry 85. p.95-106- Abstract
A new family of andrographolide analogues were synthesized and screened in vitro against kidney (HEK-293) and breast (MCF-7) cancer cells. The anti-cancer effects of the active analogues (2b, 2c and 4c) were determined by multiple cell based assays such as MTT, immunostaining, FACS, western blotting and transcriptional inhibition of NF-κB activity. Importantly, these compounds were found to possess higher anti-cancer potency than andrographolide and low toxicity to normal (VERO and MCF-10A) cells. Increased level of Bax/Bcl-xL ratio, caspase 3, and sub G1 population, higher expression level of tumor suppressor protein p53 and lower expression level of NF-κB suggested potent apoptotic property of the active analogues. Data revealed that... (More)
A new family of andrographolide analogues were synthesized and screened in vitro against kidney (HEK-293) and breast (MCF-7) cancer cells. The anti-cancer effects of the active analogues (2b, 2c and 4c) were determined by multiple cell based assays such as MTT, immunostaining, FACS, western blotting and transcriptional inhibition of NF-κB activity. Importantly, these compounds were found to possess higher anti-cancer potency than andrographolide and low toxicity to normal (VERO and MCF-10A) cells. Increased level of Bax/Bcl-xL ratio, caspase 3, and sub G1 population, higher expression level of tumor suppressor protein p53 and lower expression level of NF-κB suggested potent apoptotic property of the active analogues. Data revealed that the andrographolide derivative-mediated cell death in cancer cells was p53 dependent.
(Less)
- author
- publishing date
- 2014-10-06
- type
- Contribution to journal
- publication status
- published
- keywords
- Animals, Antineoplastic Agents/chemical synthesis, Caspase 3/metabolism, Cell Line, Tumor, Chemistry Techniques, Synthetic, Diterpenes/chemical synthesis, Glutathione/metabolism, Half-Life, Humans, Hydrolysis, NF-kappa B/metabolism, Transcription, Genetic/drug effects
- in
- European Journal of Medicinal Chemistry
- volume
- 85
- pages
- 95 - 106
- publisher
- Elsevier Masson SAS
- external identifiers
-
- pmid:25078313
- scopus:84905171913
- ISSN
- 0223-5234
- DOI
- 10.1016/j.ejmech.2014.07.088
- language
- English
- LU publication?
- no
- additional info
- Copyright © 2014 Elsevier Masson SAS. All rights reserved.
- id
- 10bfba75-5e0b-4f9f-b114-8fa40d411c47
- date added to LUP
- 2025-01-30 10:33:08
- date last changed
- 2025-06-20 14:37:53
@article{10bfba75-5e0b-4f9f-b114-8fa40d411c47, abstract = {{<p>A new family of andrographolide analogues were synthesized and screened in vitro against kidney (HEK-293) and breast (MCF-7) cancer cells. The anti-cancer effects of the active analogues (2b, 2c and 4c) were determined by multiple cell based assays such as MTT, immunostaining, FACS, western blotting and transcriptional inhibition of NF-κB activity. Importantly, these compounds were found to possess higher anti-cancer potency than andrographolide and low toxicity to normal (VERO and MCF-10A) cells. Increased level of Bax/Bcl-xL ratio, caspase 3, and sub G1 population, higher expression level of tumor suppressor protein p53 and lower expression level of NF-κB suggested potent apoptotic property of the active analogues. Data revealed that the andrographolide derivative-mediated cell death in cancer cells was p53 dependent.</p>}}, author = {{Preet, Ranjan and Chakraborty, Biswajit and Siddharth, Sumit and Mohapatra, Purusottam and Das, Dipon and Satapathy, Shakti Ranjan and Das, Supriya and Maiti, Nakul C and Maulik, Prakas R and Kundu, Chanakya Nath and Chowdhury, Chinmay}}, issn = {{0223-5234}}, keywords = {{Animals; Antineoplastic Agents/chemical synthesis; Caspase 3/metabolism; Cell Line, Tumor; Chemistry Techniques, Synthetic; Diterpenes/chemical synthesis; Glutathione/metabolism; Half-Life; Humans; Hydrolysis; NF-kappa B/metabolism; Transcription, Genetic/drug effects}}, language = {{eng}}, month = {{10}}, pages = {{95--106}}, publisher = {{Elsevier Masson SAS}}, series = {{European Journal of Medicinal Chemistry}}, title = {{Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents}}, url = {{http://dx.doi.org/10.1016/j.ejmech.2014.07.088}}, doi = {{10.1016/j.ejmech.2014.07.088}}, volume = {{85}}, year = {{2014}}, }